Sale!

CINARZIN PLUS

Original price was: 200.00৳ .Current price is: 180.00৳ .

Cinarzin Plus combines Cinnarizine and Dimenhydrinate to relieve vertigo, dizziness, and nausea caused by Meniere’s disease, motion sickness, and vascular disorders.

5 in stock

Generic Cinarzin Plus contains Cinnarizine 20mg and Dimenhydrinate 40mg, a combination medication for vertigo and balance disorders.

Description Cinarzin Plus is a combination medication used to treat vertigo, dizziness, and balance disorders associated with Meniere’s and labyrinthine disorders. It effectively prevents motion sickness and relieves symptoms caused by vascular and circulatory issues.

Benefits: Cinarzin Plus provides relief from vertigo, dizziness, and nausea. It also improves circulation, reduces vascular spasms, and prevents motion sickness. The combination of Cinnarizine and Dimenhydrinate is more effective than individual drugs alone in managing balance disorders.

Ingredients The active ingredients in Cinarzin Plus are Cinnarizine 20mg and Dimenhydrinate 40mg.

Uses and Doses Cinarzin Plus treats Meniere’s disease, vertigo, dizziness, labyrinthine disorders, and motion sickness.

  • Adults: One tablet three times daily after meals.
  • It is not recommended for adolescents under 18 years old.
  • Elderly: Same dosage as adults.

Side Effects Common side effects include drowsiness, dry mouth, headache, and stomach pain. Rare side effects include vision impairment, allergic reactions, light sensitivity, difficulty urinating, weight gain, constipation, chest tightness, jaundice, restlessness, and severe skin reactions.

How to Use: Take Cinarzin Plus after meals to reduce stomach discomfort. Swallow the tablet whole with water. Avoid alcohol and other sedatives as they may enhance drowsiness.

Pregnancy & Lactation Cinarzin Plus should be avoided during pregnancy and breastfeeding unless prescribed by a doctor.

Precautions and Warnings: Patients with hypotension, glaucoma, Parkinson’s disease, or seizure disorders should use Cinarzin Plus with caution. Alcohol and CNS depressants should be avoided while taking this medication.

Safety Information: Do not take Cinarzin Plus if you are allergic to Cinnarizine, Dimenhydrinate, or excipients. Consult your doctor before use if you have any underlying health conditions. If severe side effects occur, discontinue use and seek medical advice.

Cinarzin Plus is indicated for treating vertigo, dizziness, balance disorders, motion sickness, vascular disorders, and post-apoplectic conditions.

Pharmacology Cinnarizine is a calcium channel blocker that improves circulation and reduces arterial spasms, while Dimenhydrinate is an antihistamine that reduces nausea and dizziness. The combination effectively treats vestibular disorders and prevents motion sickness.

Therapeutic Class Anti-vertigo medications.

Storage Conditions Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children.

3 FAQ

  1. Can Cinarzin Plus be taken daily? Yes, it can be taken daily as prescribed by a doctor.
  2. How long does Cinarzin Plus take to work? It may take a few hours to relieve symptoms.
  3. Can I take Cinarzin Plus for motion sickness? Yes, it is effective in preventing and treating motion sickness.

Disclaimer: This information is for educational purposes only. Always consult a doctor before taking any medication.

 

 

 

 

Keywords:  Cinnarizine, Dimenhydrinate, anti-vertigo, motion sickness remedy, dizziness relief, nausea treatment, circulatory health, Meniere’s disease, balance disorders, vestibular disorders, tinnitus relief, labyrinthitis treatment, vascular disorders, migraine prevention, Ibn Sina Pharmaceuticals, travel sickness, antihistamine, calcium channel blocker, dizziness medication, vertigo prevention, balance therapy.

Additional information

Weight 0.2 kg
Dimensions 4 × 2 × 3 in
Class - Dosage

TABLETS

Pharmaceuticals

IBN SINA

Size

20 MG

Brand

Ibn Sina Pharmaceuticals Ltd.

Reviews

There are no reviews yet.

Be the first to review “CINARZIN PLUS”

Your email address will not be published. Required fields are marked *